Lazard Asset Management Portfolio holdings
AUM
$72.7B
1-Year Return
14.89%
This Quarter Return
+1.92%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$79.7B
AUM Growth
-$2.55B
(-3.1%)
Cap. Flow
-$8.7B
Cap. Flow
% of AUM
-10.91%
Top 10 Holdings %
Top 10 Hldgs %
26.07%
Holding
2,504
New
414
Increased
840
Reduced
685
Closed
192
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$882M |
| 2 |
Apple
AAPL
|
+$350M |
| 3 |
Marvell Technology
MRVL
|
+$304M |
| 4 |
UnitedHealth
UNH
|
+$239M |
| 5 |
Old Dominion Freight Line
ODFL
|
+$218M |
Top Sells
| 1 |
Chevron
CVX
|
+$797M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$481M |
| 3 |
Labcorp
LH
|
+$296M |
| 4 |
Pinnacle West Capital
PNW
|
+$290M |
| 5 |
Walt Disney
DIS
|
+$288M |
Sector Composition
| 1 | Technology | 26.48% |
| 2 | Financials | 13.94% |
| 3 | Healthcare | 12.34% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Floor & Decor
FND
$9.74B
| $188K | ﹤0.01% |
1,907
+864
| +83% | +$85.2K |
|
1402
MillerKnoll
MLKN
$1.44B
| $188K | ﹤0.01% |
7,169
-9,427
| -57% | -$247K |
|
|
ITCI
1403
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $188K | ﹤0.01% |
2,763
+1,766
| +177% | +$120K |
|
1404
First Horizon
FHN
$11.5B
| $187K | ﹤0.01% |
+11,963
| New | +$187K |
|
1405
Kimball Electronics
KE
$742M
| $187K | ﹤0.01% |
8,531
-440
| -5% | -$9.65K |
|
1406
Duke Energy
DUK
$95B
| $186K | ﹤0.01% |
+1,859
| New | +$186K |
|
1407
Synovus
SNV
$7.19B
| $186K | ﹤0.01% |
+4,653
| New | +$186K |
|
1408
Teradata
TDC
$2.04B
| $185K | ﹤0.01% |
+5,391
| New | +$185K |
|
1409
MYR Group
MYRG
$2.78B
| $184K | ﹤0.01% |
+1,356
| New | +$184K |
|
1410
Arcos Dorados Holdings
ARCO
$1.49B
| $182K | ﹤0.01% |
20,312
+8,755
| +76% | +$78.4K |
|
1411
Conduent
CNDT
$458M
| $182K | ﹤0.01% |
55,988
+32,577
| +139% | +$106K |
|
1412
LeMaitre Vascular
LMAT
$2.13B
| $182K | ﹤0.01% |
2,221
+568
| +34% | +$46.5K |
|
1413
Semrush
SEMR
$1.13B
| $182K | ﹤0.01% |
13,610
+8,555
| +169% | +$114K |
|
1414
Ligand Pharmaceuticals
LGND
$3.26B
| $181K | ﹤0.01% |
2,166
+981
| +83% | +$82K |
|
1415
Markel Group
MKL
$24.8B
| $181K | ﹤0.01% |
+115
| New | +$181K |
|
1416
AeroVironment
AVAV
$12.1B
| $180K | ﹤0.01% |
989
+396
| +67% | +$72.1K |
|
1417
Globus Medical
GMED
$8.05B
| $179K | ﹤0.01% |
2,623
+175
| +7% | +$11.9K |
|
1418
A.O. Smith
AOS
$10.4B
| $178K | ﹤0.01% |
2,188
-229
| -9% | -$18.6K |
|
1419
Atkore
ATKR
$2.09B
| $177K | ﹤0.01% |
1,318
-1,564
| -54% | -$210K |
|
1420
Winmark
WINA
$1.82B
| $177K | ﹤0.01% |
503
+284
| +130% | +$99.9K |
|
1421
FRP Holdings
FRPH
$485M
| $176K | ﹤0.01% |
6,183
+3,669
| +146% | +$104K |
|
|
NOA
1422
North American Construction
NOA
$393M
| $176K | ﹤0.01% |
9,142
+4,995
| +120% | +$96.2K |
|
1423
Century Communities
CCS
$2.06B
| $174K | ﹤0.01% |
+2,137
| New | +$174K |
|
|
WIRE
1424
DELISTED
Encore Wire Corp
WIRE
| $174K | ﹤0.01% |
607
-150
| -20% | -$43K |
|
1425
Apollo Global Management Series A
APO.PRA
$2.08B
| $173K | ﹤0.01% |
+2,652
| New | +$173K |
|